Effective production of a thermostable α-glucosidase from Sulfolobus solfataricus in Escherichia coli exploiting a microfiltration bioreactor

A microfiltration (MF) membrane bioreactor was developed for an efficient production of a recombinant thermostable α‐glucosidase (rSsGA) from Sulfolobus solfataricus MT‐4. The aim of the membrane bioreactor was to improve the control of the concentration of key components in the growth of genetic en...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biotechnology and bioengineering 2000-12, Vol.70 (6), p.670-676
Hauptverfasser: Schiraldi, C., Martino, A., Acone, M., Di Lernia, I., Di Lazzaro, A, Marulli, F., Generoso, M., Cartenì, M., De Rosa, M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A microfiltration (MF) membrane bioreactor was developed for an efficient production of a recombinant thermostable α‐glucosidase (rSsGA) from Sulfolobus solfataricus MT‐4. The aim of the membrane bioreactor was to improve the control of the concentration of key components in the growth of genetic engineered microorganisms, such as Escherichia coli. The influence of medium composition was studied in relation to cell growth and α‐glucosidase production. The addition of components such as yeast extract and tryptone resulted in a higher enzyme production. High cell density cultivation of E. coli BL21(DE3) on semidefined medium, exploiting a microfiltration bioreactor, was studied in order to optimize rSsGA production. In addition to medium composition, the inducer employed (either isopropyl β‐D‐thiogalactopyranoside or lactose), the induction duration, and the cultivation mode influenced both the final biomass and the enzyme yield. The MF bioreactor allowed a cell concentration of 50 g/L dry weight and a corresponding α‐glucosidase production of 11,500 U/L. The improvement obtained in the enzyme production combining genetic engineering and the microfiltration strategy was estimated to be 2,000‐fold the wild‐type strain. © 2000 John Wiley & Sons, Inc. Biotechnol Bioeng 70: 670–676, 2000.
ISSN:0006-3592
1097-0290
DOI:10.1002/1097-0290(20001220)70:6<670::AID-BIT9>3.0.CO;2-7